HCPCS G0482: Drug test(s), definitive, 15–21 drug classes

Obtain a list of documentation and billing requirements to use correctly and bill for HCPCS G0482 from our short guide.

## **What is HCPCS code G0482?** HCPCS code G0482 is a code with a long description of: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays...),(2) stable isotope or other universally recognized internal standards in all samples..., and (3) method or drug-specific calibration and matrix-matched quality control material...; qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed The code refers to robust, confirmatory laboratory analyses capable of accurately identifying individual drugs and distinguishing structural isomers (though not necessarily stereoisomers). Its purpose is to accurately identify specific drugs and metabolites, as well as distinguish between closely related compounds in a sample (e.g., urine, oral fluid, and blood drug testing). This testing is typically executed using advanced methodologies, such as gas chromatography–mass spectrometry (GC/MS) or liquid chromatography–mass spectrometry (LC/MS), whether single or tandem variants. It excludes enzymatic methods, like those using alcohol dehydrogenase, and immunoassays (e.g., EIA, ELISA). The procedure involves: - Use of stable isotope or universally recognized internal standards across all samples to manage matrix effects, interferences, and signal variability; - Calibration protocols or drug-specific validation with matrix-matched quality control materials; - Inclusion of specimen validity testing; - Analysis of 15–21 drug classes, including metabolites, per day, per patient

## **HCPCS code G0482 documentation requirements** Thorough and detailed documentation is crucial for establishing medical necessity and ensuring reimbursement. Key requirements often include: - **Written order**: A written order from the treating provider must be in the patient's medical record, explicitly indicating the medical necessity for a definitive drug test and all the drugs/drug classes to be tested. - **Medical necessity**: The patient's medical record (e.g., history and physical, progress notes) must clearly support the reason for the test. This typically involves documenting the specific clinical indicators that led to ordering the test: a high pre-test probability of non-adherence, illicit drug use, or a need to confirm the use of prescribed medications; and the patient's condition or circumstances (e.g., unexplained coma, suspected overdose, or chronic pain management with suspected non-compliance). - **Specific to G0482**: Because G0482 covers 15-21 drug classes, the medical record documentation must specifically justify the medical necessity for testing this high number of drug classes. - **Lab results**: The laboratory performing the service must maintain hard copy documentation of the lab results and copies of the ordering provider's order. - **Patient identification**: All documentation must be legible and include appropriate patient identification information and the identity of the responsible physician/practitioner.

## **G0482 billing requirements** To avoid any denial of claims, healthcare providers must keep the following billing requirements in mind when billing HCPCS code G0482: - **Unit of service**: G0482 is a "per day" code, meaning it should be billed only once per patient per date of service, regardless of the number of individual tests performed within the 15-21 drug classes. - **Drug class count**: The code selection must align with the total number of drug classes (including metabolites, if performed) tested. - **Exclusivity**: Only one definitive drug testing G-code may be billed per patient per day. - **Specimen Validity Testing (SVT)**: The code description for G0482 explicitly states it includes specimen validity testing. Therefore, separate codes for SVT (if performed on the same date) should not be billed. - **Presumptive testing on the same day**: Payers often allow a presumptive drug test and a definitive drug test (G-codes) to be billed on the same date of service if medically necessary and fully documented.

## **Other relevant codes** -**G0480**: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed - **G0481**: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed - **G0483**: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed - **G0659**: Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers, qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes

Frequently asked questions

Not necessarily. Some payers require a presumptive screen first, while others allow direct definitive testing when clinically justified. Documentation should support either approach.

Yes, but only one definitively billed G-code and one presumptively billed CPT code are permitted per patient per date of service. Each code encompasses specimen validity testing.

G0482 is for definitive drug testing, which can be either qualitative (identifies presence/absence) or quantitative (identifies concentration), as specified in the long description.